Status | Study |
Recruiting |
Study Name: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma Condition: Renal Cell Carcinoma Hereditary Leiomyomatosis and Renal Cell Cancer Date: 2015-07-08 Interventions: Drug: Vandetanib Vandetanib is |
Recruiting |
Study Name: A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer Condition: HLRCC Metastatic Papillary RCC Date: 2010-05-25 Interventions: Drug: Bevacizumab Commercially |
Completed |
Study Name: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin Condition: Cutaneous Leiomyomas Hereditary Leiomyomatosis and Renal Cell Cancer Date: 2009-09-03 Interventions: Biological: Botulinum toxin type A |